Solesence, Inc. - Common stock (SLSN)
Basic Materials › Perfumes, Cosmetics & Other Toilet Preparations
Price History
Feb 9, 2026 — May 15, 2026Investment Snapshot
- Trading 410% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 3/9 — signs of financial weakness
- ROE of 5.1% — below-average profitability
- Revenue growing at 19% annually
Solesence, Inc. - Common stock (SLSN) is a Basic Materials company operating in Perfumes, Cosmetics & Other Toilet Preparations, listed on the NASDAQ , with a market capitalisation of $93 million . Key value metrics: P/E ratio 107.5, P/B ratio 5.45, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Solesence, Inc. - Common stock — Fundamental Analysis Summary
Solesence, Inc. - Common stock (SLSN) is currently trading 410% above its Graham Number of $0.26, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 107.5x.
On financial health, SLSN shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and modest return on equity of 5.1% (sector average: -1.2%), and minimal leverage with a debt-to-equity ratio of 0.06.
StockPik's composite Value Score for SLSN is 42/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SLSN reports a moderate gross margin of 25.5% (sector average: 33.0%) and a modest operating margin of 1.4%.
SLSN shows revenue growing at 19% year-over-year, with earnings declining at 58%.